WAY-100635 is a potent dopamine D4 receptor agonist

被引：0
作者：
Benjamin R. Chemel
Bryan L. Roth
Blaine Armbruster
Val J. Watts
David E. Nichols
机构：
[1] Purdue University,Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences
[2] Psychiatry,Departments of Biochemistry
[3] Neurosciences and NIMH Psychoactive Drug Screening Program,undefined
[4] Case Western Reserve University Medical School,undefined
来源：
Psychopharmacology | 2006年 / 188卷
关键词：
WAY-100635; WAY-100634; 5-HT; D; D; Receptor selectivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：244 / 251
页数：7
相关论文
共 45 条
[31]   The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D1 agonist and D2 antagonist [J].
Sridhar Natesan ;
Greg E. Reckless ;
Karen B. L. Barlow ;
John Odontiadis ;
José N. Nobrega ;
Glen B. Baker ;
Susan R. George ;
David Mamo ;
Shitij Kapur .
Psychopharmacology, 2008, 199 :275-289
[32]   Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl) cyclohexanecarboxamide (WAY-100635) for the 5-HT1A receptor [J].
Al Hussainy, Rana ;
Verbeek, Joost ;
van der Born, Dion ;
Booij, Jan ;
Herscheid, J. D. M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (12) :5728-5735
[33]   The effect of central and systemic injection of the 5-HT1A receptor agonist 8-OHDPAT and the 5-HT1A receptor antagonist WAY100635 on periaqueductal grey-induced defence behaviour [J].
Beckett, S ;
Marsden, CA .
JOURNAL OF PSYCHOPHARMACOLOGY, 1997, 11 (01) :35-40
[34]   The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats [J].
Edward G. Meloni ;
Michael Davis .
Psychopharmacology, 2004, 174 :228-236
[35]   SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile [J].
Yves Claustre ;
Danielle De Peretti ;
Philippe Brun ;
Christiane Gueudet ;
Nathalie Allouard ;
Richard Alonso ;
Joëlle Lourdelet ;
André Oblin ;
Gabrielle Damoiseau ;
Dominique Françon ;
Marie-Françoise Suaud-Chagny ;
Régis Steinberg ;
Mireille Sevrin ;
Hans Schoemaker ;
Pascal George ;
Philippe Soubrié ;
Bernard Scatton .
Neuropsychopharmacology, 2003, 28 :2064-2076
[36]   Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study [J].
R A Lahti ;
R C Roberts ;
E V Cochrane ;
R J Primus ;
D W Gallager ;
R R Conley ;
C A Tamminga .
Molecular Psychiatry, 1998, 3 :528-533
[37]   SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. II: Behavioral Profile Predictive of an Atypical Antipsychotic Activity [J].
Ronan Depoortere ;
Denis Boulay ;
Ghislaine Perrault ;
Olivier Bergis ;
Michel Decobert ;
Dominique Françon ;
Mireille Jung ;
Jacques Simiand ;
Philippe Soubrié ;
Bernard Scatton .
Neuropsychopharmacology, 2003, 28 :1889-1902
[38]   The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats [J].
Krista Spiller ;
Zheng-Xiong Xi ;
Xiao-Qing Peng ;
Amy H. Newman ;
Charles R. Ashby ;
Christian Heidbreder ;
József Gaál ;
Eliot L. Gardner .
Psychopharmacology, 2008, 196 :533-542
[39]   SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit [J].
J.-P. Terranova ;
C. Chabot ;
M.-C. Barnouin ;
G. Perrault ;
R. Depoortere ;
G. Griebel ;
B. Scatton .
Psychopharmacology, 2005, 181 :134-144
[40]   Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors [J].
Mark J. Millan ;
Loretta Iob ;
Jean-Louis Péglion ;
Anne Dekeyne .
Psychopharmacology, 2007, 191 :767-782
12345